期刊文献+

硫氧化还原蛋白还原酶在58例肺腺癌中的表达

Thioredoxin reductase1 mRNA expression in 58 cases with lung adenocarcinoma
下载PDF
导出
摘要 目的:探讨硫氧化还原蛋白还原酶(thioredoxin reductase,TrxR1)mRNA在58例肺腺癌中的表达及其临床意义。方法:原位杂交法检测58例肺腺癌蜡块组织和10例癌旁正常肺组织中TrxR1 mRNA的表达。结果:TrxR1 mRNA在肺腺癌组织中的表达高于癌旁正常组织,但差别无统计学意义(P>0.05),在低分化组织中表达阳性率高于中高分化组织,差别具有统计学意义(P<0.05)。在直径小于3cm,3cm-5cm之间及大于5cm的肺腺癌组织中的表达差别具有统计学意义(P<0.05),在有淋巴结转移的肺腺癌组织中表达高于无淋巴结转移者,差别具有统计学意义(P<0.05)。结论:TrxR1 mRNA的表达与肺腺癌之间有密切的关系。 Objective:To investigate the expression of thioredoxin reduetasl (TrxR1)mRNA in 58 cases with lung adenocarcinoma. Methods: The expression of TrxRlmRNA was detected in 58 cases lung adenocarcinoma tissues and 10 cases adjacent normal lung tissues by means of hybridization in situ. Results: The positive rate of TrxR1 mRNA in lung adenocarcinoma tissues was 32. 8% ,higher than that in adjacent normal lung tissues which was 20% ( P 〉 0.05 ). TrxR1mRNA was related to the degree of differentiation, the positive rate in low degree of differentiation was higher than that in high degree (P 〈 0.05 ), expression of TrxR1 mRNA was significantly different between less than 3cm,3 -5cm and over 5cm on diameter(P 〈 0.05). The difference of the expression of TrxR1mRNA in the patients with and without lymph nodes metastasis was also significant (P 〈 0.05). Conclusion: The expression of TrxR1 mRNA was closely related to lung adenocarcinoma.
出处 《现代肿瘤医学》 CAS 2008年第10期1697-1699,共3页 Journal of Modern Oncology
基金 黑龙江省自然科学基金资助项目(编号:D200523) 哈尔滨市科技局课题资助项目(编号:2005AFXXJ049) 黑龙江省卫生厅课题
关键词 肺腺癌 硫氧化还原蛋白还原酶 原位杂交 adenocarcinoma of lung thioredoxin reductase in situ hybridization
  • 相关文献

参考文献10

  • 1笪冀平,杨玲.人非小细胞肺癌中KGF mRNA的表达及意义[J].临床与实验病理学杂志,2006,22(3):332-335. 被引量:1
  • 2Takashi Tamura, and Thressa C, Stadtman. A new selenoprotein from human lung adenocarcinoma cells : Prification, properties, and thioredoxin reductase activity[ J]. Proc Natl Acad Sci USA, 1996, 93:1006-1011.
  • 3Karimpour S,Lou J ,Lin LL,et al. Thioredoxin reductase regulates AP - 1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizin gradiation [ J]. Oncogene,2002,21 (41) :6317 -6327.
  • 4Xia L, Nordman T, Olsson JM, et al. Themammalian cytosolic selenoenzyme thioredoxin reductase reduces ubiquinone. A novel mechanism for defense against oxidative stress[ J]. J Biol Chem,2003, 278(4) :2141 -2146.
  • 5Kim MR, Chang HS, Kim BH, et al. Involvements of mitochondrial thioredoxin reductase ( TrxR2 ) in cell proliferation [ J ]. Biochem Biophys Rese Commun,2003,304 : 119 - 124.
  • 6Nguyen P, Awwad RT, Smart DD, et al. Thioredoxin reductase as a novel molecular target for cancer therapy [ J ]. Cancer Lett, 2006, 236(2) :164 - 174.
  • 7Zhao F, Yah J, Deng L, et al. A thioredoxin reductase inhibitor induces growth inhibition and apoptosis in five cultured human carcinoma cell lines[ J]. Cancer Lett ,2006,236( 1 ) :46 - 53.
  • 8Cunnea P, Fernandes AP, Capitanio A, et al . Increased expression of specific thioredoxin family proteins; a pilot immunohistochemical study on human hepatocellular carcinoma [ J ]Int J Immunopathol Pharmacol,2007,20( 1 ) : 17 - 24.
  • 9Haapasalo H, Kylaniemi M, Paunul N, et al. Expression of antioxidant enzymes in astrocytic brain tumors[ J]. Brain Pathol,2003,13 (2) :155 - 164.
  • 10Lincoln DT, AliEmadi EM, Tonissen KF, et al. The thioredoxin - thioredoxin reductase system : over - expression in human cancer [ J ]. Anticancer Res,2003,23 ( 3 B) :2425 - 2433.

二级参考文献10

  • 1周春辉,王华新,李晓楠,孙雷,宋波,郑仁恕,李连宏.肺癌中p63与p53、E-cadherin、Ki-67表达的比较[J].临床与实验病理学杂志,2004,20(4):432-435. 被引量:11
  • 2Guo L F, Degenstein L, Fuchs E. Keratinocyte growth factor is required for hair development but not for wound healing[J].Genes Dev, 1996, 10:165-175.
  • 3Simnet W S, DeRose M L, Bucay N, et al. Pulmonary malformation in transgenic mice expressing human keratinocyte growth factor in the lung[J]. Proc Natl Acad Sci USA, 1995, 92(26):12461- 12465.
  • 4Rubin J S, Osada H, Finch D W, et al. Purification and characterization of a newly identified growth factor specific for epithelial cell[J]. Proc Natl Acad Sci USA, 1989, 86:802 -806.
  • 5Weme S. Keratinocyte growth factor. A unique player in epithelial repair processes [J].Cytokine-Growth Factor Rev, 1998, 9 ( 2 ) :153 - 165.
  • 6Taniguchi f, Harada T, Ito M, et al. Keratinocyte growth factor in the promotin of human chorionic gonadotropin production in human choriocarainoma cells [ J ]. Am J Obstet Gynecol, 2000,182 ( 3 ) :629 - 699.
  • 7Shinatori M, Oshika E, Ling P U, et al. Keratinocyte growth factor and embryonic rat Lung morphogenesis [ J ]. Am J Respir Cell Mol Biol, 1996, 15:328 - 338.
  • 8Giri D, Ropiquet F, Ittmann M, Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer[J]. Clin Cancer Res, 1999, 5(5):1053 -1071.
  • 9Knerer B, Fonmanek M, Schickinger P, et al. Different KGF expression in squamous cell carcinomas of the head and neck and in normal mucosa[J]. Acta Otolaryngol (Stockh) , 1998,118:438-442.
  • 10Partridge M, Kiguwa S, Luqmani Y, et al. Expression of bFGP,KGF, and FGF receptors on normal oral mucosa and SCC[J]. Eur J Cancer B Oral Oncol,1996, 32B: 76 -82.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部